Department of Maternal and Child Health, School of Public Health, Sun Yat-sen University, Guangzhou, Guangdong, China.
School of Biological Engineering, Dalian Polytechnic University, Dalian, Liaoning, China.
Gut Microbes. 2023 Dec;15(2):2281350. doi: 10.1080/19490976.2023.2281350. Epub 2023 Nov 27.
Our previous work revealed that unbalanced dietary intake was an important independent factor associated with constipation and gastrointestinal (GI) symptoms in children with autism spectrum disorder (ASD). Growing evidence has shown the alterations in the gut microbiota and gut microbiota-derived metabolites in ASD. However, how the altered microbiota might affect the associations between unbalanced diets and GI symptoms in ASD remains unknown. We analyzed microbiome and metabolomics data in 90 ASD and 90 typically developing (TD) children based on 16S rRNA and untargeted metabolomics, together with dietary intake and GI symptoms assessment. We found that there existed 11 altered gut microbiota (FDR-corrected P-value <0.05) and 397 altered metabolites (P-value <0.05) in children with ASD compared with TD children. Among the 11 altered microbiota, the , , and were positively correlated with constipation (FDR-corrected P-value <0.25). The Eggerthellaceae was positively correlated with total GI symptoms (FDR-corrected P-value <0.25). More importantly, three increased microbiota including , , and Eggerthellaceae positively modulated the associations of unbalanced dietary intake with constipation and total GI symptoms, and the decreased negatively modulated their associations in ASD children (P-value <0.05). Together, the altered microbiota strengthens the relationship between unbalanced dietary intake and GI symptoms. Among the altered metabolites, ten metabolites derived from microbiota (, , Eggerthellaceae, and ) were screened out, enriched in eight metabolic pathways, and were identified to correlate with constipation and total GI symptoms in ASD children (FDR-corrected P-value <0.25). These metabolomics findings further support the modulating role of gut microbiota on the associations of unbalanced dietary intake with GI symptoms. Collectively, our research provides insights into the relationship between diet, the gut microbiota, and GI symptoms in children with ASD.
我们之前的工作表明,饮食摄入不平衡是自闭症谱系障碍(ASD)儿童便秘和胃肠道(GI)症状的一个重要独立因素。越来越多的证据表明,ASD 患者的肠道微生物群和肠道微生物衍生代谢物发生了改变。然而,改变的微生物群如何影响饮食不平衡与 ASD 患者 GI 症状之间的关联尚不清楚。我们基于 16S rRNA 和非靶向代谢组学分析了 90 名 ASD 儿童和 90 名典型发育(TD)儿童的微生物组和代谢组学数据,同时评估了饮食摄入和 GI 症状。我们发现,与 TD 儿童相比,ASD 儿童存在 11 种改变的肠道微生物群(FDR 校正 P 值<0.05)和 397 种改变的代谢物(P 值<0.05)。在 11 种改变的微生物群中,、和呈正相关与便秘(FDR 校正 P 值<0.25)。Eggerthellaceae 与总胃肠道症状呈正相关(FDR 校正 P 值<0.25)。更重要的是,三种增加的微生物群包括、和 Eggerthellaceae 正向调节饮食不平衡与便秘和总胃肠道症状的关联,而减少的则负向调节其在 ASD 儿童中的关联(P 值<0.05)。总的来说,改变的微生物群增强了饮食不平衡与 GI 症状之间的关系。在改变的代谢物中,从微生物群中筛选出 10 种代谢物(、、Eggerthellaceae 和),它们富集在八个代谢途径中,并被确定与 ASD 儿童的便秘和总胃肠道症状相关(FDR 校正 P 值<0.25)。这些代谢组学发现进一步支持了肠道微生物群对饮食不平衡与 GI 症状关联的调节作用。总的来说,我们的研究提供了关于 ASD 儿童饮食、肠道微生物群和 GI 症状之间关系的见解。